CCR5 and cancer: We have shown that the reciprocal mechanism that directs the mobilization of PMN-MDSC is CCR5-dependent, thus mice lacking CCR5 display a high state of resistance to cancer diseases that could be overridden by adoptive transfer of MDSC from WT mice [130].